Imoro Zeba Braimah

Imoro Zeba Braimah

Auto-generated profile, based on publicly available information

Imoro Zeba Braimah

Department of Surgery, Ophthalmology Unit, University of Ghana Medical School, Korle Bu, Accra, Ghana

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2010 in Eye
Verified
Journal Article
Closed access
VEV A Essuman
V A Essuman
IBI Z Braimah
I Z Braimah
TNT A Ndanu
T A Ndanu
CNC T Ntim-Amponsah
C T Ntim-Amponsah

11 August 2018 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
SSSumit Randhir Singh
Sumit Randhir Singh
MSMichael W Stewart
Michael W Stewart
GCGoura Chattannavar
Goura Chattannavar
MEMohamed Elmasry
Mohamed Elmasry
ASAhmed Souka
Ahmed Souka
Jay ChhablaniJay Chhablani
Jay Chhablani
Purpose To analyse the pooled safety data of intravitreal ziv-aflibercept (IVZ) therapy for various retinal conditions. Methods This was a retrospective, observational study which included patients from 14 participating centres who received IVZ. The medical records of patients who received IVZ from March 2015 through October 2017 were evaluated. Patient demographics and ocular details were compiled. Ocular and systemic adverse events that occurred within 1 month of IVZ injections were recorded and defined as either procedure-related or drug-related. Results A total of 1704 eyes of 1562 patients received 5914 IVZ injections (mean±SD: 3.73±3.94) during a period of 2.5 years. The age of patients was 60.6±12.8 years (mean±SD) and included diverse chorioretinal pathologies. Both ocular (one case of endophthalmitis, three cases of intraocular inflammation, and one case each of conjunctival thinning/necrosis and scleral nodule) and systemic adverse events (two cases of myocardial infarction, one case of stroke and two deaths) were infrequent. Conclusion This constitutes the largest pooled safety report on IVZ use and includes patients from 14 centres distributed across the globe. It shows that IVZ has an acceptable ocular and systemic safety profile with incidences of adverse events similar to those of other vascular endothelial growth factor inhibitory drugs. The analysis supports the continued use of IVZ in various retinal disorders.

5 August 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
IBImoro Zeba Braimah
Imoro Zeba Braimah
CEChristabel Enweronu-Laryea
Christabel Enweronu-Laryea
ASAdziri Harold Sackey
Adziri Harold Sackey
EKErnest Kenu
Ernest Kenu
KAKofi Agyabeng
Kofi Agyabeng
VEVera A. Essuman
Vera A. Essuman
Objective To determine the incidence of retinopathy of prematurity (ROP) and any associated risk factors among preterm infants at the Neonatal Intensive Care Unit (NICU) of Korle-Bu Teaching Hospital (KBTH). Design Prospective study. Setting Level 3 NICU of KBTH from June 2018 to February 2019. Participants Eligible infants with birth weight (BW) less than 2 kg or gestational age (GA) less than 37 weeks were examined at scheduled intervals until full maturity of their retina. Outcome measures The primary outcome measure was cumulative incidence of ROP and secondary outcome measure was risk factors associated with ROP. Results Of the 401 infants, 222 were females (55.4%), mean±SD GA was 32.3±2.4 weeks (median 32, IQR 31 to 34) and mean BW 1.6±0.4 kg (median 1.5, IQR 1.3 to 1.9). The cumulative incidence of ROP was 13.7% (95% CI: 10.5 to 17.5%), with 1.8% (seven infants) having type 1 ROP. Increased risk of ROP was observed in babies with supplemental oxygen exposure (p<0.001), BW less than 1.5 kg (p=0.019), confirmed neonatal sepsis (p=0.001), nasogastric tube feeding (p=0.03) and poor pupillary dilation (0.032). A reduced risk of ROP was observed in boys (p=0.004) and after delivery by caesarean section (p=0.019). Conclusion The rates of ROP at KBTH are comparable to other NICUs in sub-Saharan Africa. Birth weight less than 1.5 kg, confirmed neonatal sepsis, nasogastric tube feeding and poor pupil dilation were independently associated with increased incidence of ROP. ROP screening should be a part of the routine service for premature infants in Ghana.

24 January 2017 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
IBImoro Zeba Braimah
Imoro Zeba Braimah
MSMichael Stewart
Michael Stewart
CVChetan Videkar
Chetan Videkar
CDChintan J Dedhia
Chintan J Dedhia
JCJay Chhablani
Jay Chhablani
Aim To report the short-term outcomes of eyes with choroidal neovascularisation (CNV) associated with causes other than age-related macular degeneration (AMD) after treatment with intravitreal ziv-aflibercept (IVZ) injections. Methods This retrospective study included eyes with non-AMD-related CNV that were treated with IVZ (1.25 mg/0.05 mL) on a pro re nata basis. The primary outcome measure is the mean change in best-corrected visual acuity (BCVA) and secondary outcome measures include the mean change in central macular thickness (CMT) and adverse events. Results 23 eyes of 19 patients with CNV due to high myopia (9), macular telangiectasia (4), central serous chorioretinopathy (3), choroidal osteoma (2), choroiditis (2), Best's disease (2) and idiopathic (1) were treated. The mean follow-up period was 4±1.9 months. The median number of IVZ injections was 1 (range, 1–3) and the median treatment-free interval at the time of the final visit was 3 months (range, 1–8). The mean BCVA improved from 0.67 LogMAR to 0.58 LogMAR (p=0.0507). Nine of 23 (39%) eyes had BCVA gains of at least 0.1 LogMAR, 11 (48%) eyes had stable BCVA (within 0.1 LogMAR of baseline) and 3 (13%) eyes had a BCVA decline of at least 0.1 LogMAR at the final visit. The mean CMT improved significantly from baseline until the final visit (22 vs 174.5 μm; p=0.037). No ocular or systemic adverse events were noted. Conclusions IVZ improves CMT in patients with CNV associated with causes other than AMD, but improvements in BCVA are modest.

1 March 2017 in Retina
Verified
Journal Article
Closed access
IBImoro Z. Braimah
Imoro Z. Braimah
SDSunila Dumpala
Sunila Dumpala
JCJay Chhablani
Jay Chhablani
To evaluate the occurrence and characteristics of outer retinal tubulation (ORT) in an Indian population with retinal dystrophies. In this retrospective study, 309 eyes of 157 patients with retinal dystrophies including retinitis pigmentosa (RP, 183 eyes), Stargardt disease (STGD, 93 eyes) and Best disease (33 eyes) were reviewed. The demographic details, clinical data including visual acuity, treatment history and good quality spectral domain optical coherence tomography (SD-OCT) scans were collected. The characteristics of ORT including location, number, type, associated intraretinal fluid, disruption of outer retina and presence of other lesions were recorded. ORT was detected in 12 eyes of 8 patients (unilateral in 4 eyes). Their mean age was 42.5 ± 13.89 yrs. (range, 21-60 yrs.), the mean baseline best corrected visual acuity was 0.425 ± 0.7 LogMAR (Snellen equivalent 20/53) and the median follow up was 6 months. The frequency of ORT were; 6 out of 183 (3%) eyes in RP, 2 out of 93 (2%) eyes in STGD, and 4 out of 33 (12%) eyes with Best disease and this difference in frequency was found to be statistically significant (χ = 6.93, p = 0.03). The average number of ORT in each eye was 2.75 ± 2.0 and the mean height of ORT was 40.8 ± 15.4 μm. Three eyes had co-existing choroidal neovascularization. All eyes had tubular structures except one that had the branching type. The ORT in 2 eyes of one patient with Best disease who had 3 years follow up data was found to be stable over the entire period. ORTs are present in patients with RP, STGD and Best disease with a higher frequency in Best disease.

17 August 2016 in Seminars in Ophthalmology
Verified
Journal Article
Closed access
IBImoro Zeba Braimah
Imoro Zeba Braimah
SRShruthi Rapole
Shruthi Rapole
SDSunila Dumpala
Sunila Dumpala
Jay ChhablaniJay Chhablani
Jay Chhablani
Aim: To investigate the presence of focal choroidal excavation (FCE) in patients with retinitis pigmentosa (RP), Stargardt’s disease (STGD), and Best disease in the Indian population. Methods: This retrospective consecutive case series included 309 eyes of 157 patients with RP (183 eyes), STGD (93 eyes), and Best disease (33 eyes) with good-quality, enhanced-depth spectral domain optical coherence tomography scans. Comprehensive ophthalmic examination data were collected. Characteristics of FCE, including location of FCE, type (conforming and non-conforming), maximal width, and depth, were noted. Results: FCE was found in 2 out of 33 (6%) eyes with Best disease and no FCE was found in eyes with RP or STGD. The location of the FCE was extrafoveal in both cases. The first case had non-conforming FCE while the second case had the conforming type and the FCE occurred in association with choroidal neovascularization in the second case. The first case maintained good visual acuity of 20/20 over the entire period of follow-up (14 months), while the second case had a visual acuity of 20/200 at the last follow-up (three years) due to scarred choroidal neovascular membranes. The FCE showed no change in both eyes over the entire duration of follow-up. Conclusion: Focal choroidal excavation was found in 6% of eyes with Best disease, which remained stable throughout follow up. Eyes with RP and STGD did not have any FCE. Further studies are required to determine the role of vitelliform material in FCE development in Best disease.